Immuno-peptides may have positive or negative effects on gonadal steroidogenesis, but few have been tested outside of rodent species or in vivo. In Exp. 1, thymulin, a secreted nonapeptide of the thymus, was incubated (1, 10, 100, or 1,000 ng/mL) with testicular minces (sampled at 3, 6, or 12 h ) from Chinese Meishan boars of high gonadotropin/testicular steroidogenic function ( n = 8 ) and White composite boars of European origin ( n = 8 ) to test the hypothesis that thymulin could augment hCG stimulation of testicular androgen concentrations. Thymulin alone had few effects on androgen concentrations (testosterone, dehydroepiandrosterone+dehydroepiandrosterone sulfate [DHEA+DHEASO 4 ] ) in Meishan boar testicular incubates. In minces from White composites incubated with thymulin, testosterone concentrations were generally below control values ( P < .05), but DHEA+DHEASO 4 concentrations were unaffected. Thymulin had no effect on estrone concentrations in testicular incubates of White composite boars but stimulated estrone concentrations in Meishan testicular incubates. Thymulin plus hCG increased testosterone ( 3 and 6 h of incubation; P < .05) but not DHEA+DHEASO 4 concentrations in White composite testicular incubates. Thymulin plus hCG did not alter androgen or estrogen concentrations from control values in Meishan testicular incubates. In Exp.2 with a protocol similar to that of Exp. 1 for testicular minces from White composite boars ( n = 30), thymulin increased testosterone concentrations during the early incubation period ( 1 to 3 h; P < .05) and depressed testosterone concentrations at later times ( 6 h; P < .05). Thymulin synergized with hCG in stimulating increases in testosterone and DHEA+DHEASO 4 concentrations ( P < .05) but had no effect on estrone concentrations in vitro. Thymulin was tested in vivo in boars from three genetic lines selected for high, medium, or normal circulating LH concentrations (Meishan, select White composites, and control White composites, respectively). Injection of thymulin i.v. (4.4, 44.4, or 444.4 ng/kg BW) generally increased circulating testosterone concentrations ( 2 to 3 h later; P < .01), but the response was dependent on the boar's general circulating LH concentrations and dose of thymulin. Overall results from these studies support the hypothesis of a thymulin augmentation of LH stimulation of androgen increases in vitro and in vivo in the testis of boars.
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Immuno-peptides may have positive or negative effects on gonadal steroidogenesis, but few have been tested outside of rodent species or in vivo. In Exp. 1, thymulin, a secreted nonapeptide of the thymus, was incubated (1, 10, 100, or 1,000 ng/mL) with testicular minces (sampled at 3, 6, or 12 h ) from Chinese Meishan boars of high gonadotropin/testicular steroidogenic function ( n = 8 ) and White composite boars of European origin ( n = 8 ) to test the hypothesis that thymulin could augment hCG stimulation of testicular androgen concentrations. Thymulin alone had few effects on androgen concentrations (testosterone, dehydroepiandrosterone+dehydroepiandrosterone sulfate [DHEA+DHEASO 4 ] ) in Meishan boar testicular incubates. In minces from White composites incubated with thymulin, testosterone concentrations were generally below control values ( P < .05), but DHEA+DHEASO 4 concentrations were unaffected. Thymulin had no effect on estrone concentrations in testicular incubates of White composite boars but stimulated estrone concentrations in Meishan testicular incubates. Thymulin plus hCG increased testosterone ( 3 and 6 h of incubation; P < .05) but not DHEA+DHEASO 4 concentrations in White composite testicular incubates. Thymulin plus hCG did not alter androgen or estrogen concentrations from control values in Meishan testicular incubates. In Exp.2 with a protocol similar to that of Exp. 1 for testicular minces from White composite boars ( n = 30), thymulin increased testosterone concentrations during the early incubation period ( 1 to 3 h; P < .05) and depressed testosterone concentrations at later times ( 6 h; P < .05). Thymulin synergized with hCG in stimulating increases in testosterone and DHEA+DHEASO 4 concentrations ( P < .05) but had no effect on estrone concentrations in vitro. Thymulin was tested in vivo in boars from three genetic lines selected for high, medium, or normal circulating LH concentrations (Meishan, select White composites, and control White composites, respectively). Injection of thymulin i.v. (4.4, 44.4, or 444 .4 ng/kg BW) generally increased circulating testosterone concentrations ( 2 to 3 h later; P < .01), but the response was dependent on the boar's general circulating LH concentrations and dose of thymulin. Overall results from these studies support the hypothesis of a thymulin augmentation of LH stimulation of androgen increases in vitro and in vivo in the testis of boars.
Introduction
Functions of immuno-peptides outside of the regulatory and control aspects on the immune system are now being elucidated (Adashi, 1990; Pollanen et al., 1990) . Secretory products from media of macrophage, splenic, and thymic cell cultures can stimulate (Yee and Hutson, 1985; Gorospe and Kasson, 1988; Hughes et al., 1990; Uzumcu and Lin, 1994) or inhibit ovarian and testicular steroidogenesis (Aguilera and Romano, 1989; Reyes-Esparza and Romano, 1989; Watson et al., 1994) . Within the testis reside numerous immune cells (Hermo and Lalli, 1978; Pollanen and Maddocks, 1988; Setchell et al., 1990; Bergh et al., 1993; Gaytan et al., 1994; Pinilla et al., 1994; Wang et al., 1994) , and the potential for local immunoregulation of testicular function is under evaluation Skinner, 1991; Hutson, 1992; Gaytan et al., 1996) . Thymulin, a peptide produced by thymic epithelial cells, can affect many endocrine systems (Bach and Dardenne, 1989; Dardenne and Savino, 1994) . Ovarian responses to thymulin include a thymulin-augmented gonadotropic increase in granulosa maturation and progesterone secretion (Ledwitz-Rigby and Scheid, 1991) and an increase in ovarian weights and ovulation rates (Hinojosa and Rosas, 1996) , but little is known about the effects of thymulin on testicular function. In vitro testicular steroidogenic activity from Meishan boars that have increased gonadotropins compared to boars of European origin may be a more sensitive model for thymulin augmentation of LH stimulation of testicular steroidogenesis. Our objectives for this study were to monitor the effects of thymulin on testicular steroidogenesis in vitro and in vivo and to test for the thymulin-augmented hCG stimulation of testicular steroid synthesis in Chinese Meishan and European crossbred boars.
Methods
Porcine Testis Incubations
Testicular minces (500 mg) were prepared from contemporary meat-type White composite ( n = 8; BW = 156 ± 3.3 kg; Ô Chester White, Ô Landrace, Ô Large White, Ô Yorkshire) and Chinese Meishan ( n = 8; BW = 147 ± 4 kg) boars. For differences in serum concentrations of LH of the two genetic lines, boars were bled from jugular cannulas. On two different days, boars were bled every 20 min for 2 h for a total of 12 serum samples per boar.
Testicular minces were incubated in 5 mL of TC199 (tissue culture media 199 with L-glutamine; Gibco Labs, Grand Island, NY) with sodium bicarbonate (pH 7.4) in 25-mL Erlenmeyer flasks in an atmosphere of 95:5 (oxygen:carbon dioxide) at 35°C. Treatments consisted of 0, 1, 10, 100, or 1,000 ng/mL of thymulin (American Peptide Co., Sunnyvale, CA) with or without hCG ( 1 IU/mL, Sigma Chemical Co., St Louis, MO). Incubates were sampled (.5 mL) at 3, 6, and 12 h for quantification of testosterone, dehydroepiandrosterone/dehydroepiandrosterone sulfate ( DHEA+DHEASO 4 ) , or estrone release into the media. In a second experiment, testicular minces (500 mg) from three replicates of White composite boars ( n = 40; BW = 90 to 100 kg) were incubated using the same protocol as the prior testicular incubates, except media were sampled at 1, 3, and 6 h for later assay of testosterone, DHEA+DHEASO 4 , or estrone.
Boar Thymulin Injections
Jugular catheters were placed into White composite boars that had been selected from a large population for increased serum gonadotropins ( n = 7; LH = .50 ± .02), White composite boars of normal gonadotropin concentrations ( n = 6; LH = .28 ± .02), and Chinese Meishan boars ( n = 6; LH = .73 ± .08 ng/mL) to characterize in vivo effects of thymulin on serum changes in concentration of testosterone or estrone. The increased gonadotropins found in Chinese Meishan and selected White composite boars may provide a sensitive in vivo model for the gonadotropic synergism of thymulin treatment on testicular androgen release. Animals were sampled every 20 min for 2 h for a preinjection control period, then thymulin was injected via the jugular catheter. After thymulin injection, animals were sampled every 10 min for 30 min and then sampled every 20 min for 3.5 h. Boars were randomized to initially receive the low ( n = 10; 4.4 ng/kg BW) or medium ( n = 9; 44 ng/kg BW) dose of thymulin, and then 26 d later the high dose of thymulin was administered ( n = 10; 440 ng/kg BW), which corresponded with physiological to pharmacological levels (Davis et al., 1994) . This thymulin treatment protocol minimized any prior treatment influencing subsequent responses. Thymulin was solubilized in .1% barrow serum in physiological saline (.5 to 1 mL) and flushed with copious volumes of saline into the jugular catheter. All experiments were performed in accordance with protocols approved by the Animal Care Committee at the U.S. Meat Animal Research Center in accordance with the NASULGC (1988).
Assays
Serum was analyzed for testosterone, total DHEA+DHEASO 4 , estrone, or LH with established RIA (Ford et al., 1980; Wise et al., 1995 Wise et al., , 1996b . Concentrations of DHEA and DHEASO 4 (hereafter referred to as DHEA+DHEASO 4 ) are high in boars (Wise et al., 1995) and readily interconvertible; thus, total concentrations of the two may be descriptively more useful. Interassay variation for testosterone or DHEA+DHEASO 4 was less than 10% for either assay. Interassay variation for estrone was 12.5%. The interassay CV for LH was 3.3%.
Data from testicular incubations or in vivo hormonal changes were analyzed with the split plot model of the general linear model procedure (Data Desk 4 , 1994) . Main effects were breed, thymulin dose, and time, with breed and treatment effects tested with the breed × treatment interaction nested within boar. Testicular incubation weights were used as a covariate to adjust for any weight differences of incubations. In vivo effects of thymulin were analyzed with the split plot model of the general linear model procedure with each boar acting as its own control (first 120 min of preinjection concentrations; paired t-test) (Snedecor and Cochran, 1974) . Percentage changes in testosterone concentrations for in vivo alterations after thymulin injection were computed by averaging the pretreatment concentrations ( 2 h preinjection) and dividing into the values after thymulin injection (5.5 h after thymulin injection). Post hoc test for comparisons of differences of least squares ( L S ) means was by the LSD procedure.
Results
In Vitro Thymulin Effects
In an initial in vitro analysis, tissue samples from testis from European White composite boars ( n = 8 ) and Chinese Meishan boars ( n = 8 ) were incubated with various doses of thymulin ( 1 to 1,000 ng/mL) or thymulin plus hCG. Pituitary function was considerably increased in Chinese Meishan boars compared with crossbred boars of European origin (LH = 1.3 ± .1 and .17 ± .07 ng/mL for Meishan and White composite boars, respectively), resulting in increased circulating testosterone concentrations in Meishan boars. Concentrations of testosterone decreased with time of incubation (control and treated), and thymulin treatment ( 1 to 100 ng/mL) lowered testosterone concentrations below those of control incubations from testis of White composite boars (Figure 1a ; P < .05). Changes in testosterone synthesis from testicular incubates treated at 1,000 ng/mL of thymulin were not different from control values. In incubations with hCG plus thymulin, testosterone concentrations increased at 3 and 6 h of incubation (Figure 1b ; P < .05) but were not different from control values at 12 h. Unlike responses in White composites, testicular incubates from Meishan testis continued to increase release of testosterone into the media up to 12 h of incubation, and thymulin had no effect on concentrations of testosterone (Figure 1c, d) .
Concentrations of DHEA+DHEASO 4 were monitored as an alternative pathway of testicular androgen synthesis. Concentrations of DHEA+DHEASO 4 were decreased in thymulin-treated testicular incubates of White composite boars at 3 h (Figure 2a ; P < .05). Few changes in DHEA+DHEASO 4 concentrations from 6 to 12 h of incubation were noted. Incubations with thymulin plus hCG did not increase DHEA+DHEASO 4 concentrations over control concentrations. Although not significantly different, most incubates treated with thymulin plus hCG had reduced DHEA+DHEASO 4 concentrations compared with controls ( Figure 2b ). In Meishan testicular incubates, there was a tendency for thymulin treatment to increase DHEA+DHEASO 4 concentrations at 3 h of incubation (Figure 2c ; P < .10). With the addition of hCG to various thymulin doses, Meishan testicular incubates produced nonsignificant decreases of DHEA+DHEASO 4 at 3 and 6 h of incubation (Figure 2d) . At 12 h of incubation, DHEA+DHEASO 4 concentrations in most thymulin plus hCG incubates were comparable to control concentrations in Meishan testicular incubates (Figure 2d ).
Declines in testosterone concentrations during incubation may indicate conversion to other steroidal metabolites such as estrogens. Estrone concentrations in testicular incubates with thymulin from White composite boars were reduced but not significantly different from control incubates (Figure 3a) . In Meishan boar testicular incubates, all doses of thymulin stimulated estrone concentrations in comparison to control values (Figure 3c ; P < .01). No thymulinaugmented, hCG-stimulated increases in estrone concentrations from White composite or Meishan testicular incubates were noted (Figure 3b, d ).
Because androgen concentrations had already decreased at the first sampling ( 3 h ) after thymulin treatment in White composite testicular incubates of the first experiment, earlier changes in androgen synthesis might reflect different responses to thymulin. Testicular incubates from White composite boars ( n = 40) were sampled at 1, 3, or 6 h. At 1 h of incubation, testosterone concentrations at most thymulin doses were increased over controls and continued to increase to 3 h of incubation (Figure 4a ; P < .01). Thymulin treatment of testicular incubates generally reduced DHEA+DHEASO 4 concentrations (Figure 4c ; P < .10). Addition of hCG with various doses of thymulin showed increases in androgen accumulation in the media over control incubates by 3 h. Androgen concentrations decreased (testosterone) or reached a plateau (DHEA+DHEASO 4 ) by 6 h (Figure 4b,d ; P < .05). The lowest doses of thymulin generally produced the greatest increases in androgen synthesis in vitro. As with responses to thymulin and thymulin plus hCG in the first incubation experiment (Figures 1 and 2) , estrone concentrations were decreased in treated incubates but were not statistically different from control incubate values ( Figure  4e, f) .
In Vivo Thymulin Effects
Because in vitro testis incubations showed surprising biphasic responses to thymulin treatment, an in vivo analysis of effects of thymulin on circulating steroid concentrations was pursued. In vivo effects of thymulin were tested in boars of three genetic lines that differed by high, medium, or low circulating concentrations of LH (Chinese Meishan, LH = .73; selected White composites for increased gonadotropins, LH = .5; and control White composites, LH = .28 ng/mL). Time, dose, and thymulin treatment resulted in an increase of circulating testosterone concentrations in nearly all doses of the White composite boars (Figure 5a ; P < .01). The medium Figure 1 . Changes in testosterone concentrations (mean ± SEM) from White composite (n = 8) and Chinese Meishan (n = 8) boar testicular incubates when incubated with thymulin (0 to 1,000 ng/mL) or thymulin plus human chorionic gonadotropin (hCG; 1 IU/mL). Each testicular incubate was sampled three times per dose of thymulin. Thymulin treatment decreased testosterone concentrations at 1 to 100 ng/mL of thymulin in White composite boars (a; P < .05) but had no effect on Chinese Meishan testicular synthesis of testosterone (c). Thymulin plus hCG increased (P < .05) testosterone concentrations at 3 and 6 h of incubation in White composite testicular incubates (b), but no thymulin augmentation of hCG stimulation was noted in Meishan testicular incubates (d).
dose of thymulin produced the greatest increases in testosterone concentrations in White composite boars ( P < .01). The genetic line × dose interaction was significant. On a percentage increase basis after thymulin injection (adjusted to 0% at time of injection from 2-h preinjection values), White composite boars selected for increased gonadotropins had a 40 to 50% increase in testosterone concentrations, whereas White composite controls had only a 20 to 30% increase in testosterone concentrations (Figure 5b, d ; P < .01). Testosterone concentrations in Meishan boars after thymulin injection increased 35% at the high dose of thymulin ( P < .01) but had one of the highest peak responses to thymulin (Figure 5f ). No increases in circulating estrone concentrations were noted in the White composite control, White composite high gonadotropin line, or Meishan boars from thymulin injection (Figure 6 ). Figure 2 . Changes in dehydroepiandrosterone plus its sulfate form (DHEA+DHEASO 4 ) concentrations (mean ± SEM) from White composite (n = 8) and Chinese Meishan (n = 8) boar testicular incubates when incubated with thymulin (0 to 1,000 ng/mL) or thymulin plus human chorionic gonadotropin (hCG; 1 IU/mL). Each testicular incubate was sampled three times per dose of thymulin. In White composite testicular incubates at 3 h, DHEA+DHEASO 4 concentrations were decreased from control values (a; P < .05) but were not different at 6 and 12 h of incubation. No significant changes in DHEA+DHEASO 4 were noted in Meishan testicular incubates in response to thymulin (c). No thymulin augmentation of hCG stimulation of DHEA+DHEASO 4 synthesis was noted in incubates of White composite or Meishan boars (b, d).
Discussion
Gonadal steroids can feed back on thymulin secretion from the thymus (Dardenne et al., 1986) . Savino et al. (1988) found that both testosterone and estradiol could stimulate the release of thymulin from thymic epithelial cells, and athymic male mice have reduced gonadotropins and testosterone concentrations (Rebar et al., 1982) . Thymic peptide factors can also inhibit hCG/LH binding in rat testis (Hirart and Romano, 1986) or stimulate release of gonadotropins (Zaidi et al., 1988; Spangelo et al., 1989; Mendoza et al., 1995) . Thymulin can augment the gonadotropin stimulation of steroidogenesis in male and female Figure 3 . Changes in estrone concentrations (mean ± SEM) from White composite (n = 8) and Chinese Meishan (n = 8) boar testicular incubates when incubated with thymulin (0 to 1,000 ng/mL) or thymulin plus human chorionic gonadotropin (hCG; 1 IU/mL). Each testicular incubate was sampled three times per dose of thymulin. Estrone concentrations did not differ with time or dose in White composite testicular incubates (a), but thymulin stimulated estrone concentrations in testicular incubates from Meishan boars (c; P < .01). No thymulin augmentation of hCG stimulation of estrone was noted in testicular incubates of White composite or Meishan boars (b, d).
rodents (Ledwitz-Rigby and Scheid, 1991; Wise, 1998) , but no information is available on effects of thymic peptides in vitro or in vivo using farm animals.
Meishan boars have increased gonadotropins; thus, we thought that their testicular incubates might be a sensitive model for thymulin/hCG augmentation of testosterone secretion. In the initial incubation of boar testis with thymulin, there was a distinct difference in response to thymulin and thymulin plus hCG between White composite and Chinese Meishan boars. Testicular incubates from Meishan boars demonstrated no response to thymulin in vitro in relation to changes in testosterone concentrations. Also, testis from Meishan boars continued to increase release of testosterone into media to 12 h of incubation, whereas concentrations of testosterone in White composite boars decreased. Decreases in steroid concentrations during the incubation extended time ( 6 to 12 h ) could indicate conversion to other metabolites; thus, changes in DHEA+DHEASO 4 and estrone were monitored. Figure 4 . Changes of testosterone, dehydroepiandrosterone plus its sulfate form (DHEA+DHEASO 4 ), and estrone concentrations (mean ± SEM) in testicular minces incubated with thymulin (a, c, e; 0 to 1,000 ng/mL) or thymulin plus human chorionic gonadotropin (hCG; b, d, f) from three replicates of White composite boars (n = 40). Each testicular incubate was sampled three times per dose of thymulin. At 1 and 3 h of incubation with thymulin, testosterone concentrations were increased (P < .01) but at 6 h they were not different from controls. A thymulin augmentation of hCG-stimulated increases in testosterone and DHEA+DHEASO 4 concentrations was noted by 3 h of incubation (b, d ), but by 6 h values were not different from control values. Estrone concentrations were not different from control incubate values. Thymulin had little effect on DHEA+DHEASO 4 concentrations in vitro from either breed of boars. All doses of thymulin increased estrone concentrations from Meishan boar testis but had no effect on estrone concentrations from White composite testicular incubations.
Although Meishan boar testis responded to hCG with increases of testosterone concentrations, thymulin treatment had no effect in augmenting the hCG stimulation of testosterone increases in vitro. There was an increase in testosterone, but not DHEA+DHEASO 4 , concentrations from testis treated with hCG plus thymulin from White composite boars, which is similar to the report of thymulin synergizing with hCG in stimulating granulosa increases of progesterone concentrations in vitro (Ledwitz-Rigby and Scheid, 1991) .
The 3-to 12-h incubation protocol in the initial boar testis incubation was used primarily to focus on the possible hCG-thymulin synergistic effects on testosterone concentrations (providing adequate time to increase synthesis of p450 enzyme systems and responses), whereas responses to thymulin may have occurred much earlier. The second incubation of boar testis was sampled at earlier periods ( 1 to 3 h ) and used increased numbers of boars ( n = 40). Thymulin stimulated testosterone concentrations in media at 1 h of incubation, possibly at the expense of DHEA+DHEASO 4 synthesis. Early increases in testosterone concentrations from thymulin treatment may be the result of thymulin augmentation with endogenous gonadotropins occupying receptors before tissue harvest. By 3 h of incubation, testosterone concentrations were further increased, whereas DHEA+DHEASO 4 remained unchanged or lower than in controls. As indicated in the initial incubations of boar testis, testosterone concentrations declined below control values by 6 h of incubation with thymulin treatment. In testicular incubates from White composites, thymulin synergized with hCG to stimulate testosterone concentrations greater than control incubations that received only hCG. Concentrations of DHEA+DHEASO 4 were also increased at 3 h of incubation but by 6 h were no different from concentrations in controls. As in the first testicular incubation experiment, thymulin had little effect on estrone concentrations in White composite testis incubates, which may indicate some specificity in response that is restricted to androgens. Lack of a dose response to different concentrations of thymulin in vitro is of concern, but little is known about circulating concentrations of thymulin in pigs. Although treatment levels of thymulin were chosen to cover a wide span, concentrations chosen may have still been excessive, as indicated by a trend in the highest concentrations of thymulin to be associated with decreased testosterone concentrations.
Although the second in vitro experiment offered convincing evidence of thymulin stimulation of androgen increases in boars, the complexities and interactions in a total-body response to thymulin would provide further evidence of thymulin's effects on gonadal steroidogenesis. In vivo injection of thymulin into boars generally resulted in an initial decrease of testosterone concentrations after thymulin injection. Approximately 2 to 3 h after thymulin injection, testosterone concentrations increased. Estrone concentrations after injection of thymulin in vivo were surprisingly unaffected in both breeds of boars, which supports the in vitro results in that effects of thymulin seem limited to androgens. Thymulin stimulation of estrone concentrations in Meishan boars noted in vitro was not found in vivo, which may be the result of quick conversion to estrone sulfate, the major estrogen circulating in boars (Schwarzenberger et al., 1993) . Boars from the three genetic models with varying endogenous LH concentrations did seem to support the augmentation of thymulin with LH in increasing testosterone secretion. As a percentage increase in testosterone concentrations over preinjection values, White composite boars selected for elevated gonadotropins had the greatest response to thymulin, and White composite controls had the least response to thymulin. Meishan boars that have the highest gonadotropins had an intermediate response to thymulin (high dose). Because the sampling schedule of in vivo effects of thymulin was initiated at 0700, it was noticed that the diurnal decline in testosterone concentrations in Meishan boars was much greater than in European crossbred boars. The hypothesis that the increased gonadotropins noted in Meishan boars might make a sensitive model for the thymulin augmentation of LH-stimulated androgen synthesis was not supported in vitro or in vivo. Biological and endocrine evidence indicates that the Meishan breed is quite different from European breeds in many ways (Wise et al., 1996b; Ford et al., 1997) .
Due to the many complex interactions involved with Leydig cell function, some differences of in vitro and in vivo results are to be expected (Saez, 1994) . The mechanism by which circulating testosterone decreased and subsequently increased from thymulin treatment in vivo is unknown (concentrations of many of the thymulin-treated boars were still increasing at the end of the 6-h bleeding period), but it does support in vitro incubation responses to thymulin in that at some incubation times thymulin decreased synthesis of androgens and at other periods stimulated androgens in comparison to control incubates. The increases in circulating testosterone concentrations after thymulin injection in boars may be related to pituitary release of LH by thymulin (Zaidi et al., 1988) , but LH-induced increases in testosterone concentrations in boars occur within 15 to 20 min after increases of LH (Wise et al., 1996b) . Increases in testosterone after thymulin injection occurred 2 to 3 h later and do not seem compatible with thymulin-induced pituitary release of LH.
The cultures used for testicular incubations were a mixed cell population (Sertoli, Leydig, immunological); thus, determination of a direct or indirect mechanism of action of thymulin on Leydig cells may be particularly challenging. A possible scenario of events after treatment with thymulin may involve a complex alteration of cytokine/lymphokine release from the numerous immunological cell types found in the testis (Calkins et al., 1988; Verhoeven et al., 1988; Fauser et al., 1989; Gaytan et al., 1996) in which some factors resulted in decreases and others stimulated increases in testicular steroid synthesis. Also, alterations in steroid concentrations in vivo do not always relate to synthesis and release, because changes in clearance could also modify circulating concentrations. One item of interest is that thymulin increases testosterone concentrations even though testosterone has such a negative impact on thymic weight and peptide secretion (Wise, 1992; Wise et al., 1996a) .
In conclusion, there seems to be evidence of a positive effect of thymulin on testicular androgen accumulation, but it has little effect on estrone concentrations. In vivo results of this study with boars and an earlier study with rats (Wise, 1998 ) support aspects of thymulin augmentation of gonadotropin stimulation of androgen production by testis. It has long been established that gonadal steroids feed back on thymic function; thus, the importance of these observations is to provide evidence of thymic endocrine effects on gonadal steroidogenesis and provide foundation information on a thymic-testicular feedback system. Responses to thymulin and thymulin plus hCG were different in Meishan and European White composite boars. What is most obvious from these studies is that thymulin is just one component of a complex series of endocrine and paracrine events in controlling testicular steroidogenesis.
Implications
Outside of rodent species, little is known about the impact of immunological peptides on gonadal function. The testis has a large population of resident immunological cells that may affect the secretion of steroids and germ cell development via paracrine actions of the numerous lymphokines, cytokines, and peptide factors from immunological cells. Thymulin, a nonapeptide from immunological cells, augments the stimulation of testicular androgen secretion by human chorionic gonadotropin both in vitro and in vivo in boars. Further understanding of the roles of immunological peptides may not only have important health aspects for farm animals but also may alter our concepts of gonadal function.
